Icecure Medical Ltd (NASDAQ:ICCM) has seen 1.68 million shares traded in the last trading session. The company, currently valued at $41.98M, closed the last trade at $0.71 per share which meant it gained $0.11 on the day or 19.02% during that session. The ICCM stock price is -121.13% off its 52-week high price of $1.57 and 32.39% above the 52-week low of $0.48. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.01 million shares traded. The 3-month trading volume is 620.54K shares.
The consensus among analysts is that Icecure Medical Ltd (ICCM) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.08.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Icecure Medical Ltd (NASDAQ:ICCM) trade information
Sporting 19.02% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the ICCM stock price touched $0.71 or saw a rise of 6.13%. Year-to-date, Icecure Medical Ltd shares have moved -33.44%, while the 5-day performance has seen it change 17.25%. Over the past 30 days, the shares of Icecure Medical Ltd (NASDAQ:ICCM) have changed 29.49%. Short interest in the company has seen 0.28 million shares shorted with days to cover at 0.46.
Wall Street analysts have a consensus price target for the stock at $5.75, which means that the shares’ value could jump 87.65% from current levels. The projected low price target is $5.75 while the price target rests at a high of $5.75. In that case, then, we find that the current price level is -709.86% off the targeted high while a plunge would see the stock gain -709.86% from current levels.
Icecure Medical Ltd (ICCM) estimates and forecasts
Figures show that Icecure Medical Ltd shares have outperformed across the wider relevant industry. The company’s shares have lost -30.85% over the past 6 months, with this year growth rate of 15.63%, compared to 4.30% for the industry. Revenue growth from the last financial year stood is estimated to be 23.98%.
2 analysts offering their estimates for the company have set an average revenue estimate of 708.5k for the current quarter. 2 have an estimated revenue figure of 1.29M for the next ending quarter. Year-ago sales stood 327k and 1.25M respectively for this quarter and the next, and analysts expect sales will grow by 116.67% for the current quarter and 23.98% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -0.26% over the past 5 years.
ICCM Dividends
Icecure Medical Ltd is expected to release its next earnings report in December this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Icecure Medical Ltd (NASDAQ:ICCM)’s Major holders
The top two institutional holders are CITADEL ADVISORS LLC with over 0.17 million shares worth more than $0.13 million. As of 2024-06-30, CITADEL ADVISORS LLC held 0.3627% of shares outstanding.
The other major institutional holder is RENAISSANCE TECHNOLOGIES LLC, with the holding of over 66400.0 shares as of 2024-06-30. The firm’s total holdings are worth over $49136.0 and represent 0.1421% of shares outstanding.
